Anticorps Monoclonal anti-IgG2b Isotype Control

IgG2b Isotype Control Monoclonal Antibody for FC

Hôte / Isotype

Mouse / IgG2b, kappa

Réactivité testée

n/a

Applications

FC

Conjugaison

APC Fluorescent Dye

Publications(4)

CloneNo.

MPC-11

N° de cat : APC-65128

Synonymes

Ighg2b, MPC-11, Igh-3, IgG2b, gamma2b

---

Galerie de données de validation

• 

  FC experiment of human PBMCs using APC-65128

  1X10^6 human PBMCs were surface stained with 0.2 ug APC Anti-Mouse IgG2b Isotype Control (APC-65128, Clone:MPC-11) (red), APC Anti-Human CD20 (black), or unstained (blue). Cells were not fixed. Lymphocytes were gated.

---

Applications testées

• Résultats positifs en cytométrie: CMSP humaines,

Dilution recommandée

Application	Dilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Applications publiées

• FC: See 3 publications below

Informations sur le produit

APC-65128 cible IgG2b Isotype Control dans les applications de FC et montre une réactivité avec des échantillons n/a

• Réactivité: n/a
• Hôte / Isotype: Mouse / IgG2b, kappa
• Clonalité: Monoclonal
• Type: Anticorps
• Immunogène: s/o
• Nom complet: immunoglobulin heavy chain 3 (serum IgG2b)
• Symbole du gène: IgG2b Isotype Control
• Identification du gène (NCBI): 16016
• Conjugaison: APC Fluorescent Dye
• Excitation/Emission maxima wavelengths: 650 nm / 660 nm
• Forme: Liquide
• Méthode de purification: Purification par affinité
• Tampon de stockage: PBS with 0.09% sodium azide and 0.5% BSA
• Conditions de stockage: Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Informations générales

The MPC-11 immunoglobulin is useful as an isotype-matched control. The MPC-11 immunoglobulin has an unknown binding specificity and is used as an isotype control for mouse IgG2b antibodies. This antibody has been quality-tested for flow cytometry as negative control.

Publications

Species	Application	Title
	FC	MedComm (2020); CircMALAT1 promotes cancer stem-like properties and chemoresistance via regulating Musashi-2/c-Myc axis in esophageal squamous cell carcinoma; Authors - Zitong Zhao
		Adv Mater; An OMV-Based Nanovaccine as Antigen Presentation Signal Enhancer for Cancer Immunotherapy; Authors - Yichao Lu
	FC	Eur J Pharmacol; PPARγ agonist pioglitazone enhances colorectal cancer immunotherapy by inducing PD-L1 autophagic degradation; Authors - Xiao Jia
	FC	Auris Nasus Larynx; Simultaneous disturbance of NHE1 and LOXL2 decreases tumorigenicity of head and neck squamous cell carcinoma; Authors - Yuji Hayashi

{{ptg:RelatedPrimaryAntibodies}}